VanDevanter, Donald R <br/><br/>
IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis.  [electronic resource] 

 -  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society  05 2016 
 - 372-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5010 
<br/><br/><label>Standard No.: </label>10.1016/j.jcf.2015.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Adolescent<br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cystic Fibrosis--complications<br/>Episode of Care<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Respiratory Tract Infections--drug therapy<br/>Risk Assessment--methods<br/>Risk Factors<br/>Symptom Flare Up<br/>United States--epidemiology